Chemical Exposure Down With Switch in Cosmetics Among Teens

Share this content:
Chemical Exposure Down With Switch in Cosmetics Among Teens
Chemical Exposure Down With Switch in Cosmetics Among Teens

MONDAY, March 7, 2016 (HealthDay News) -- Switching to chemical-free cosmetics and shampoos quickly lowers levels of hormone-disrupting chemicals in the bodies of adolescent girls, according to a study published online March 7 in Environmental Health Perspectives.

Chemicals widely used in personal care products -- including phthalates, parabens, triclosan and oxybenzone -- have been shown to interfere with the hormone system in animals, the researchers explained. These chemicals are found in many fragrances, cosmetics, hair products, soaps, and sunscreens.

The study involved 100 Hispanic teens who used make-up, shampoo, and lotions that were labeled free of chemicals for three days. After this short break from their regular products, levels of the hormone-disrupting chemicals in the girls' urine fell between 27 and 45 percent, the researchers found.

"Because women are the primary consumers of many personal care products, they may be disproportionately exposed to these chemicals," lead author Kim Harley, Ph.D., of the Center for Environmental Research and Children's Health at the University of California, Berkeley, said in a university news release. "Teen girls may be at particular risk since it's a time of rapid reproductive development, and research has suggested that they use more personal care products per day than the average adult woman."

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »